Retour
77
Également cotée sous
AAVXF
OTC
Fourchette du Jour
115,02 €
122,97 €
Fourchette 52 Semaines
4,77 €
148,83 €
Volume
1 265 517
Moyenne 50J / 200J
119,11 €
/
87,46 €
Clôture Précédente
120,34 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -42,9 | 0,4 |
| P/B | 186,5 | 2,9 |
| ROE % | -149,0 | 3,8 |
| Net Margin % | -1633,1 | 3,9 |
| Rev Growth 5Y % | 261,8 | 10,0 |
| D/E | 2,4 | 0,2 |
Objectif de Cours des Analystes
Hold
142,50 €
+23.5%
Low: 110,00 €
High: 176,00 €
BPA Prévisionnel
-3,07 €
CA Est.
3,8 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,96 €
3,05 € – 6,87 €
|
1,5 B | 1 |
| FY2029 |
5,35 €
3,29 € – 7,41 €
|
1,2 B | 1 |
| FY2028 |
0,71 €
0,31 € – 1,11 €
|
570 M | 2 |
Points Clés
Revenue grew 261,78% annually over 5 years — strong growth
Debt/Equity of 2,40 — high leverage
Negative free cash flow of -154,72M
PEG of 0,14 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 128,24%
Capital efficient — spends only 5,96% of revenue on capex
Croissance
Revenue Growth (5Y)
261,78%
Revenue (1Y)133,54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-148,98%
ROIC-94,05%
Net Margin-1633,08%
Op. Margin-1602,89%
Sécurité
Debt / Equity
2,40
Current Ratio1,84
Interest Coverage-41,33
Valorisation
P/E Ratio
-42,94
P/B Ratio186,47
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 133,54% | Revenue Growth (3Y) | 53,45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 261,78% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10,79M | Net Income (TTM) | -176,24M |
| ROE | -148,98% | ROA | -85,88% |
| Gross Margin | 100,00% | Operating Margin | -1602,89% |
| Net Margin | -1633,08% | Free Cash Flow (TTM) | -154,72M |
| ROIC | -94,05% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,40 | Current Ratio | 1,84 |
| Interest Coverage | -41,33 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -42,94 | P/B Ratio | 186,47 |
| P/S Ratio | 701,25 | PEG Ratio | 0,14 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 7,57B | Enterprise Value | 7,52B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 10,79M | 4,62M | 4,58M | 37 000,0 | 63 000,0 |
| Net Income | -176,24M | -147,74M | -60,74M | -42,45M | -37,55M |
| EPS (Diluted) | -2,80 | -3,43 | -3,18 | -2,75 | -2,62 |
| Gross Profit | 10,79M | 4,57M | 4,47M | -119 000,0 | -33,77M |
| Operating Income | -172,98M | -127,38M | -64,84M | -41,40M | -38,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 205,23M | 327,06M | 75,54M | 109,23M | 71,30M |
| Total Liabilities | 164,64M | 131,05M | 68,36M | 83,30M | 53,40M |
| Shareholders' Equity | 40,58M | 196,01M | 7,19M | 25,93M | 17,90M |
| Total Debt | 97,36M | 58,04M | 39,16M | 51,65M | 33,99M |
| Cash & Equivalents | 144,22M | 251,94M | 26,95M | 60,70M | 29,30M |
| Current Assets | 170,67M | 285,97M | 36,18M | 75,21M | 37,67M |
| Current Liabilities | 92,83M | 88,12M | 51,46M | 32,26M | 19,41M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#5 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026